{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:51:06Z","timestamp":1793717466594,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21J21467"],"award-info":[{"award-number":["21J21467"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jpainsymman.2023.09.017","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:05:13Z","timestamp":1695693913000},"page":"39-49.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-6938","authenticated-orcid":false,"given":"Miho","family":"Takemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-9387","authenticated-orcid":false,"given":"Kazuyuki","family":"Niki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-176X","authenticated-orcid":false,"given":"Yoshiaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1609-7903","authenticated-orcid":false,"given":"Tomohiro","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6733-6453","authenticated-orcid":false,"given":"Makie","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-5037","authenticated-orcid":false,"given":"Yoshinobu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-4464","authenticated-orcid":false,"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0001","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1185\/03007990903120158","article-title":"Opioid switching and rotation in primary care: implementation and clinical utility","volume":"25","author":"Slatkin","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/FTD.0000000000000009","article-title":"Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain","volume":"36","author":"De Gregori","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0003","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/cancers12071951","article-title":"Genetics and opioids: towards more appropriate prescription in cancer pain","volume":"12","author":"Bugada","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0004","first-page":"894","article-title":"OPRM1 receptor as new biomarker to help the prediction of post mastectomy pain and recurrence in breast cancer","volume":"81","author":"De Gregori","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0005","first-page":"1423","article-title":"Pain polymorphisms and opioids: an evidence based review","volume":"19","author":"Vieira","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0006","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0007","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1093\/hmg\/dds314","article-title":"Genetic-epigenetic interaction modulates \u03bc-opioid receptor regulation","volume":"21","author":"Oertel","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0008","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0893-133X(00)00252-9","article-title":"Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve","volume":"25","author":"Sora","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/AJP.0000000000000636","article-title":"Effects of the OPRM1 A118G polymorphism (rs1799971) on opioid analgesia in cancer pain: a systematic review and meta-analysis","volume":"35","author":"Yu","year":"2019","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0011","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/ALN.0b013e318182af21","article-title":"A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia","volume":"109","author":"Sia","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0012","first-page":"131","article-title":"The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis","volume":"18","author":"Ren","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0000000000000405","article-title":"OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis","volume":"121","author":"Hwang","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0014","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","article-title":"Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients","volume":"152","author":"Klepstad","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0015","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.pnpbp.2008.07.009","article-title":"Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment","volume":"32","author":"Crettol","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0016","doi-asserted-by":"crossref","first-page":"e24750","DOI":"10.1002\/jcla.24750","article-title":"Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response","volume":"36","author":"Xie","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bcp.12576","article-title":"Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity","volume":"79","author":"Mouly","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0018","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2011.01.014","article-title":"The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (\u03bc-opioid receptor) knockout mice","volume":"491","author":"K\u00f6gel","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0019","doi-asserted-by":"crossref","first-page":"e68013","DOI":"10.1371\/journal.pone.0068013","article-title":"Validity and reliability of the Japanese version of the painDETECT questionnaire: a multicenter observational study","volume":"8","author":"Matsubayashi","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0885-3924(98)00098-0","article-title":"A brief cancer pain assessment tool in Japanese: the utility of the Japanese Brief Pain Inventory\u2013BPI-J","volume":"16","author":"Uki","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41687-017-0012-7","article-title":"Japanese translation and linguistic validation of the US National Cancer Institute's Patient-reported Outcomes version of the Common Terminology Criteria for Adverse events (PRO-CTCAE)","volume":"1","author":"Miyaji","year":"2017","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","article-title":"Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief","volume":"83","author":"Campa","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0024","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s12325-018-0778-x","article-title":"Does \u2018strong analgesic\u2019 equal \u2018strong opioid\u2019? Tapentadol and the concept of \u2018\u00b5-load\u2019","volume":"35","author":"Raffa","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3940(95)12026-Z","article-title":"Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury","volume":"199","author":"Ossipov","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3959(92)90255-A","article-title":"The depressive effect of intrathecal clonidine on the spinal flexor reflex is enhanced after sciatic nerve section in rats","volume":"51","author":"Xu","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0027","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1248\/bpb.b21-00212","article-title":"Tapentadol in cancer patients with neuropathic pain: a comparison of methadone, oxycodone, fentanyl, and hydromorphone","volume":"44","author":"Takemura","year":"2021","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0028","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/jpet.110.175042","article-title":"Synergistic interaction between the two mechanisms of action of tapentadol in analgesia","volume":"337","author":"Schr\u00f6der","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0029","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1460-9568.2011.07628.x","article-title":"Molecular basis of NMDA receptor functional diversity","volume":"33","author":"Paoletti","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0030","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eplepsyres.2010.06.010","article-title":"Inhibition of NMDA receptor\/NO signaling blocked tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice","volume":"91","author":"Ghasemi","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-1211(01)00316-3","article-title":"The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice","volume":"48","author":"Homayoun","year":"2002","journal-title":"Epilepsy Res"},{"issue":"Supplement","key":"10.1016\/j.jpainsymman.2023.09.017_bib0033","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0885-3924(99)00125-6","article-title":"NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials","volume":"19","author":"Sang","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpainsymman.2023.09.017_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1196\/annals.1316.039","article-title":"Gene polymorphisms of the mu opioid receptor in methamphetamine abusers","volume":"1025","author":"Ide","year":"2004","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423006875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423006875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:31Z","timestamp":1760132491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392423006875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0885392423006875"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.09.017","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.","name":"copyright","label":"Copyright"}]}}